genedrive plc (LSE:GDR) — Market Cap & Net Worth
Market Cap & Net Worth: genedrive plc (GDR)
genedrive plc (LSE:GDR) has a market capitalization of $125.27K (GBX1.03 Billion) as of August 3, 2026. Listed on the LSE stock exchange, this UK-based company holds position #31301 globally and #1081 in its home market, demonstrating a -4.76% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying genedrive plc's stock price GBX1.00 by its total outstanding shares 1029603992 (1.03 Billion). See genedrive plc capital spending ratio to understand how much of operating cash flow is reinvested back into capital assets.
genedrive plc Market Cap History: 2015 to 2026
genedrive plc's market capitalization history from 2015 to 2026. Data shows change from $14.89 Million to $125.27K (-37.65% CAGR).
Index Memberships
genedrive plc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
FTSE AIM All Share Index
FTAI
|
$906.99 Million | 0.01% | #336 of 722 |
Weight: genedrive plc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
genedrive plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how genedrive plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.14x
genedrive plc's market cap is 0.14 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $7.44 Million | $5.06 Million | -$5.92 Million | 1.47x | N/A |
| 2017 | $4.16 Million | $2.62 Million | -$6.59 Million | 1.59x | N/A |
| 2018 | $2.61 Million | $1.94 Million | -$7.03 Million | 1.34x | N/A |
| 2019 | $2.79 Million | $2.36 Million | -$3.64 Million | 1.18x | N/A |
| 2020 | $6.02 Million | $1.06 Million | -$19.42 Million | 5.68x | N/A |
| 2021 | $5.39 Million | $687.00K | -$691.00K | 7.84x | N/A |
| 2022 | $1.38 Million | $49.00K | -$4.67 Million | 28.12x | N/A |
| 2023 | $1.02 Million | $55.00K | -$5.15 Million | 18.51x | N/A |
| 2024 | $306.92K | $501.00K | -$7.08 Million | 0.61x | N/A |
| 2025 | $109.61K | $764.00K | -$5.23 Million | 0.14x | N/A |
Competitor Companies of GDR by Market Capitalization
Companies near genedrive plc in the global market cap rankings as of August 3, 2026.
Key companies related to genedrive plc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $215.77 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #169 globally with a market cap of $137.72 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #577 globally with a market cap of $46.48 Billion USD ( CN¥317.64 Billion CNY).
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #616 globally with a market cap of $43.83 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $215.77 Billion | $574.30 |
| #169 | Danaher Corporation | NYSE:DHR | $137.72 Billion | $194.98 |
| #577 | WuXi AppTec Co Ltd | SHG:603259 | $46.48 Billion | CN¥128.43 |
| #616 | IDEXX Laboratories Inc | NASDAQ:IDXX | $43.83 Billion | $559.07 |
genedrive plc Historical Marketcap From 2015 to 2026
Between 2015 and today, genedrive plc's market cap moved from $14.89 Million to $ 125.27K, with a yearly change of -37.65%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | GBX125.27K | +14.29% |
| 2025 | GBX109.61K | -64.29% |
| 2024 | GBX306.92K | -69.85% |
| 2023 | GBX1.02 Million | -26.14% |
| 2022 | GBX1.38 Million | -74.42% |
| 2021 | GBX5.39 Million | -10.48% |
| 2020 | GBX6.02 Million | +115.56% |
| 2019 | GBX2.79 Million | +7.14% |
| 2018 | GBX2.61 Million | -37.31% |
| 2017 | GBX4.16 Million | -44.17% |
| 2016 | GBX7.44 Million | -50.00% |
| 2015 | GBX14.89 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of genedrive plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $125.27K USD |
| MoneyControl | $125.27K USD |
| MarketWatch | $125.27K USD |
| marketcap.company | $125.27K USD |
| Reuters | $125.27K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About genedrive plc
genedrive plc engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications. The company provides Genedrive system, rapid nucleic acid thermocycler and fluorescence signal detection system for target discrimination used for qualitative in vitro molecular diagnos… Read more